(Mauritius) Pte Ltd Maxwell Sells 165,428 Shares of Amyris Inc (AMRS) Stock

Amyris Inc (NASDAQ:AMRS) major shareholder (Mauritius) Pte Ltd Maxwell sold 165,428 shares of the firm’s stock in a transaction dated Thursday, March 23rd. The stock was sold at an average price of $0.48, for a total transaction of $79,405.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

(Mauritius) Pte Ltd Maxwell also recently made the following trade(s):

  • On Monday, March 20th, (Mauritius) Pte Ltd Maxwell sold 88,382 shares of Amyris stock. The stock was sold at an average price of $0.49, for a total transaction of $43,307.18.
  • On Tuesday, March 21st, (Mauritius) Pte Ltd Maxwell sold 223,073 shares of Amyris stock. The stock was sold at an average price of $0.48, for a total transaction of $107,075.04.
  • On Friday, March 17th, (Mauritius) Pte Ltd Maxwell sold 339,908 shares of Amyris stock. The stock was sold at an average price of $0.49, for a total transaction of $166,554.92.
  • On Wednesday, March 15th, (Mauritius) Pte Ltd Maxwell sold 270,374 shares of Amyris stock. The stock was sold at an average price of $0.46, for a total transaction of $124,372.04.
  • On Monday, March 13th, (Mauritius) Pte Ltd Maxwell sold 346,429 shares of Amyris stock. The stock was sold at an average price of $0.50, for a total transaction of $173,214.50.
  • On Thursday, March 9th, (Mauritius) Pte Ltd Maxwell sold 520,925 shares of Amyris stock. The stock was sold at an average price of $0.46, for a total transaction of $239,625.50.
  • On Tuesday, March 7th, (Mauritius) Pte Ltd Maxwell sold 852,224 shares of Amyris stock. The stock was sold at an average price of $0.45, for a total transaction of $383,500.80.
  • On Friday, March 3rd, (Mauritius) Pte Ltd Maxwell sold 868,589 shares of Amyris stock. The stock was sold at an average price of $0.49, for a total transaction of $425,608.61.
  • On Wednesday, March 1st, (Mauritius) Pte Ltd Maxwell sold 377,823 shares of Amyris stock. The stock was sold at an average price of $0.51, for a total transaction of $192,689.73.
  • On Monday, February 27th, (Mauritius) Pte Ltd Maxwell sold 287,706 shares of Amyris stock. The stock was sold at an average price of $0.52, for a total transaction of $149,607.12.

Amyris Inc (NASDAQ:AMRS) opened at 0.4871 on Tuesday. Amyris Inc has a 1-year low of $0.31 and a 1-year high of $1.43. The company has a 50-day moving average of $0.51 and a 200 day moving average of $0.67. The stock’s market cap is $133.18 million.

Amyris (NASDAQ:AMRS) last announced its earnings results on Thursday, March 2nd. The company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by $0.03. The business had revenue of $32.20 million for the quarter, compared to the consensus estimate of $38.72 million. During the same quarter in the previous year, the business posted ($0.16) earnings per share. The firm’s revenue was up 228.6% compared to the same quarter last year. Analysts predict that Amyris Inc will post ($0.33) EPS for the current year.

Insider Buying and Selling by Quarter for Amyris (NASDAQ:AMRS)

COPYRIGHT VIOLATION WARNING: This story was reported by Mideast Time and is the sole property of of Mideast Time. If you are accessing this story on another site, it was stolen and reposted in violation of US & international copyright legislation. The original version of this story can be read at https://www.mideasttime.com/mauritius-pte-ltd-maxwell-sells-165428-shares-of-amyris-inc-amrs-stock/1590408.html.

A hedge fund recently raised its stake in Amyris stock. KBC Group NV raised its stake in Amyris Inc (NASDAQ:AMRS) by 330.1% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 329,101 shares of the company’s stock after buying an additional 252,589 shares during the period. KBC Group NV owned about 0.14% of Amyris worth $191,000 as of its most recent filing with the SEC. 30.40% of the stock is currently owned by institutional investors.

Several research firms recently commented on AMRS. Rodman & Renshaw reaffirmed a “buy” rating and issued a $4.00 price target on shares of Amyris in a research note on Wednesday, January 11th. HC Wainwright set a $4.00 price target on shares of Amyris and gave the stock a “buy” rating in a research note on Tuesday, January 10th. Finally, Zacks Investment Research raised shares of Amyris from a “sell” rating to a “hold” rating in a research note on Monday, January 16th.

About Amyris

Amyris, Inc is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including cosmetics, flavors and fragrances (F&F), solvents and cleaners, polymers, lubricants, healthcare products and fuels.

5 Day Chart for NASDAQ:AMRS

Receive News & Ratings for Amyris Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amyris Inc and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.